Rabies differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
| Line 24: | Line 24: | ||
!<small>Imaging preferance</small> | !<small>Imaging preferance</small> | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" |Rabies infection | ! style="background: #DCDCDC; padding: 5px; text-align:center;" |Rabies infection<ref name="pmid8489675">{{cite journal |vauthors=Baevsky RH, Bartfield JM |title=Human rabies: a review |journal=Am J Emerg Med |volume=11 |issue=3 |pages=279–86 |year=1993 |pmid=8489675 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| Line 36: | Line 36: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |[[Hydrophobia]], aerophobia, [[dysphagia]], and localized pain, [[weakness]] or [[paresthesias]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |[[Hydrophobia]], aerophobia, [[dysphagia]], and localized pain, [[weakness]] or [[paresthesias]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Meningitis]] | ! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Meningitis]]<ref name="pmid23050153">{{cite journal |vauthors=Tacon CL, Flower O |title=Diagnosis and management of bacterial meningitis in the paediatric population: a review |journal=Emerg Med Int |volume=2012 |issue= |pages=320309 |year=2012 |pmid=23050153 |pmc=3461291 |doi=10.1155/2012/320309 |url=}}</ref><ref name="pmid16474042">{{cite journal |vauthors=Chadwick DR |title=Viral meningitis |journal=Br. Med. Bull. |volume=75-76 |issue= |pages=1–14 |year=2005 |pmid=16474042 |doi=10.1093/bmb/ldh057 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| Line 54: | Line 54: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |[[Fever]], [[Neck rigidity|neck]], [[Neck rigidity|rigidity]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |[[Fever]], [[Neck rigidity|neck]], [[Neck rigidity|rigidity]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[ | ! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Encephalitis]]<ref name="pmid15804262">{{cite journal |vauthors=Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, Kennedy PG |title=Viral encephalitis: a review of diagnostic methods and guidelines for management |journal=Eur. J. Neurol. |volume=12 |issue=5 |pages=331–43 |year=2005 |pmid=15804262 |doi=10.1111/j.1468-1331.2005.01126.x |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| Line 66: | Line 66: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |Accompany a [[meningoencephalitis]], [[seizures]], [[hemiparesis]], [[cranial nerve palsies]], [[photophobia]], [[nausea]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |Accompany a [[meningoencephalitis]], [[seizures]], [[hemiparesis]], [[cranial nerve palsies]], [[photophobia]], [[nausea]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" |Autoimmune encephalitis | ! style="background: #DCDCDC; padding: 5px; text-align:center;" |Autoimmune encephalitis<ref name="pmid26754777">{{cite journal |vauthors=Lancaster E |title=The Diagnosis and Treatment of Autoimmune Encephalitis |journal=J Clin Neurol |volume=12 |issue=1 |pages=1–13 |year=2016 |pmid=26754777 |pmc=4712273 |doi=10.3988/jcn.2016.12.1.1 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | +/- | | style="background: #F5F5F5; padding: 5px; text-align:center" | +/- | ||
| Line 78: | Line 78: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |Memory deficit, [[Dyskinesia|dyskinesias]], [[seizures]], [[autonomic instability]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |Memory deficit, [[Dyskinesia|dyskinesias]], [[seizures]], [[autonomic instability]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Brain abscess|CNS abscess]] | ! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Brain abscess|CNS abscess]]<ref name="pmid24174804">{{cite journal |vauthors=Alvis Miranda H, Castellar-Leones SM, Elzain MA, Moscote-Salazar LR |title=Brain abscess: Current management |journal=J Neurosci Rural Pract |volume=4 |issue=Suppl 1 |pages=S67–81 |year=2013 |pmid=24174804 |pmc=3808066 |doi=10.4103/0976-3147.116472 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| Line 94: | Line 94: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |High grade [[fever]], [[fatigue]],[[nausea]], [[vomiting]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |High grade [[fever]], [[fatigue]],[[nausea]], [[vomiting]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" | [[Poliomyelitis]] | ! style="background: #DCDCDC; padding: 5px; text-align:center;" | [[Poliomyelitis]]<ref name="pmid19705014">{{cite journal |vauthors=Obregón R, Chitnis K, Morry C, Feek W, Bates J, Galway M, Ogden E |title=Achieving polio eradication: a review of health communication evidence and lessons learned in India and Pakistan |journal=Bull. World Health Organ. |volume=87 |issue=8 |pages=624–30 |year=2009 |pmid=19705014 |pmc=2733260 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| Line 104: | Line 104: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |Asymmetric [[paralysis]] following a flu-like syndrome | | style="background: #F5F5F5; padding: 5px; text-align:center" |Asymmetric [[paralysis]] following a flu-like syndrome | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neurosyphilis]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neurosyphilis]]<ref name="pmid15548491">{{cite journal |vauthors=Timmermans M, Carr J |title=Neurosyphilis in the modern era |journal=J. Neurol. Neurosurg. Psychiatr. |volume=75 |issue=12 |pages=1727–30 |year=2004 |pmid=15548491 |pmc=1738873 |doi=10.1136/jnnp.2004.031922 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 116: | Line 116: | ||
[[Blindness]], [[confusion]], [[depression]], abnormal [[gait]] | [[Blindness]], [[confusion]], [[depression]], abnormal [[gait]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tick paralysis]] ([[Dermacentor andersoni|Dermacentor tick]]) | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tick paralysis]] ([[Dermacentor andersoni|Dermacentor tick]])<ref name="pmid18755381">{{cite journal |vauthors=Edlow JA, McGillicuddy DC |title=Tick paralysis |journal=Infect. Dis. Clin. North Am. |volume=22 |issue=3 |pages=397–413, vii |year=2008 |pmid=18755381 |doi=10.1016/j.idc.2008.03.005 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 127: | Line 127: | ||
Tick often still latched to the patient at presentation (often in head and neck area) | Tick often still latched to the patient at presentation (often in head and neck area) | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Botulism]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Botulism]]<ref name="pmid15257512">{{cite journal |vauthors=Cherington M |title=Botulism: update and review |journal=Semin Neurol |volume=24 |issue=2 |pages=155–63 |year=2004 |pmid=15257512 |doi=10.1055/s-2004-830901 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 137: | Line 137: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |[[Diplopia]], [[Hyporeflexia|Hyporeflexia,]] [[Hypotonia]], possible respiratory paralysis, [[Floppy baby syndrome]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |[[Diplopia]], [[Hyporeflexia|Hyporeflexia,]] [[Hypotonia]], possible respiratory paralysis, [[Floppy baby syndrome]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tetrodotoxin|Tetrodotoxin poisoning]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Tetrodotoxin|Tetrodotoxin poisoning]]<ref name="pmid17425946">{{cite journal |vauthors=Hwang DF, Noguchi T |title=Tetrodotoxin poisoning |journal=Adv. Food Nutr. Res. |volume=52 |issue= |pages=141–236 |year=2007 |pmid=17425946 |doi=10.1016/S1043-4526(06)52004-2 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 147: | Line 147: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | History of consumption of puffer fish species | | style="background: #F5F5F5; padding: 5px; text-align:center" | History of consumption of puffer fish species | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Metabolic disturbances ([[electrolyte imbalance]], [[hypoglycemia]]) | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Metabolic disturbances ([[electrolyte imbalance]], [[hypoglycemia]])<ref name="pmid3966331">{{cite journal |vauthors=Josephson MA, Kaul S, Hopkins J, Kvam D, Singh BN |title=Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease |journal=Am. Heart J. |volume=109 |issue=1 |pages=41–5 |year=1985 |pmid=3966331 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | +/- | | style="background: #F5F5F5; padding: 5px; text-align:center" | +/- | ||
| Line 157: | Line 157: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |[[Confusion]], [[seizure]], [[Palpitation|palpitations]], [[sweating]], [[dizziness]], [[hypoglycemia]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |[[Confusion]], [[seizure]], [[Palpitation|palpitations]], [[sweating]], [[dizziness]], [[hypoglycemia]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Electrolyte disturbance]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Electrolyte disturbance]]<ref name="pmid3043756">{{cite journal |vauthors=Marcelou-Kinti O, Velegraki-Abel A |title=[Resistance to amphotericin B and genotypic resistance to 5-fluorocytosine of serotypes A and B of Candida albicans] |language=French |journal=Therapie |volume=43 |issue=2 |pages=121–2 |year=1988 |pmid=3043756 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 167: | Line 167: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |Possible [[arrhythmia]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |Possible [[arrhythmia]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Drug toxicity]]/[[Neuroleptic malignant syndrome]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Drug toxicity]]/[[Neuroleptic malignant syndrome]]<ref name="pmid9735957">{{cite journal |vauthors=Pelonero AL, Levenson JL, Pandurangi AK |title=Neuroleptic malignant syndrome: a review |journal=Psychiatr Serv |volume=49 |issue=9 |pages=1163–72 |year=1998 |pmid=9735957 |doi=10.1176/ps.49.9.1163 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| Line 180: | Line 180: | ||
Mental status change, rigidity, or [[dysautonomia]] | Mental status change, rigidity, or [[dysautonomia]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Organophosphate poisoning|Organophosphate toxicity]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Organophosphate poisoning|Organophosphate toxicity]]<ref name="pmid3057326">{{cite journal |vauthors=Minton NA, Murray VS |title=A review of organophosphate poisoning |journal=Med Toxicol Adverse Drug Exp |volume=3 |issue=5 |pages=350–75 |year=1988 |pmid=3057326 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 190: | Line 190: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |History of exposure to i[[Insecticide|nsecticide]] or living in farming environment with : [[Diarrhea]], [[Miosis]], [[Bradycardia]], [[Lacrimation]], [[Emesis]], [[Salivation]], [[Sweating]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |History of exposure to i[[Insecticide|nsecticide]] or living in farming environment with : [[Diarrhea]], [[Miosis]], [[Bradycardia]], [[Lacrimation]], [[Emesis]], [[Salivation]], [[Sweating]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Stroke|Ischemic stroke]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Stroke|Ischemic stroke]]<ref name="pmid20412000">{{cite journal |vauthors=Baldwin K, Orr S, Briand M, Piazza C, Veydt A, McCoy S |title=Acute ischemic stroke update |journal=Pharmacotherapy |volume=30 |issue=5 |pages=493–514 |year=2010 |pmid=20412000 |doi=10.1592/phco.30.5.493 |url=}}</ref>| style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | |||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | +/- | | style="background: #F5F5F5; padding: 5px; text-align:center" | +/- | ||
| Line 200: | Line 199: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |Sudden unilateral motor and sensory deficit in a patient with a history of [[Atherosclerosis|atherosclero<nowiki/>tic]] risk factors ([[diabetes]], [[hypertension]], smoking) or [[Atrial fibrillation|atrial fibrillation]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |Sudden unilateral motor and sensory deficit in a patient with a history of [[Atherosclerosis|atherosclero<nowiki/>tic]] risk factors ([[diabetes]], [[hypertension]], smoking) or [[Atrial fibrillation|atrial fibrillation]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemorrhagic stroke]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hemorrhagic stroke]]<ref name="pmid3443867">{{cite journal |vauthors=Bullard CW |title=Issues in low-level radioactive waste management |journal=JAPCA |volume=37 |issue=11 |pages=1337–41 |year=1987 |pmid=3443867 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 210: | Line 209: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |[[Neck stiffness]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |[[Neck stiffness]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Subdural hematoma|Subdural hemorrhage]] | ! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Subdural hematoma|Subdural hemorrhage]]<ref name="pmid16408582">{{cite journal |vauthors=Cenic A, Bhandari M, Reddy K |title=Management of chronic subdural hematoma: a national survey and literature review |journal=Can J Neurol Sci |volume=32 |issue=4 |pages=501–6 |year=2005 |pmid=16408582 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 221: | Line 220: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |[[Confusion]], [[dizziness]], [[nausea]], [[vomiting]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |[[Confusion]], [[dizziness]], [[nausea]], [[vomiting]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Hypertensive encephalopathy]] | ! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Hypertensive encephalopathy]]<ref name="pmid12803657">{{cite journal |vauthors=Schwartz RB |title=Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions |journal=Neurologist |volume=8 |issue=1 |pages=22–34 |year=2002 |pmid=12803657 |doi= |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 231: | Line 230: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |[[Delirium]], [[cortical blindness]], [[cerebral edema]], [[seizure]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |[[Delirium]], [[cortical blindness]], [[cerebral edema]], [[seizure]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Wernicke's encephalopathy|Wernicke’s encephalopathy]] | ! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Wernicke's encephalopathy|Wernicke’s encephalopathy]]<ref name="pmid26644959">{{cite journal |vauthors=Flynn A, Macaluso M, D'Empaire I, Troutman MM |title=Wernicke's Encephalopathy: Increasing Clinician Awareness of This Serious, Enigmatic, Yet Treatable Disease |journal=Prim Care Companion CNS Disord |volume=17 |issue=3 |pages= |year=2015 |pmid=26644959 |pmc=4578911 |doi=10.4088/PCC.14r01738 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 241: | Line 240: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |[[Ophthalmoplegia]], [[confusion]] | | style="background: #F5F5F5; padding: 5px; text-align:center" |[[Ophthalmoplegia]], [[confusion]] | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center" |[[Amyotrophic lateral sclerosis]] | ! style="background: #DCDCDC; padding: 5px; text-align:center" |[[Amyotrophic lateral sclerosis]]<ref name="pmid26629397">{{cite journal |vauthors=Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A |title=A comprehensive review of amyotrophic lateral sclerosis |journal=Surg Neurol Int |volume=6 |issue= |pages=171 |year=2015 |pmid=26629397 |pmc=4653353 |doi=10.4103/2152-7806.169561 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 251: | Line 250: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |Patient initially presents with [[upper motor neuron]] deficit ([[spasticity]]) followed by [[lower motor neuron]] deficit ([[flaccidity]]) | | style="background: #F5F5F5; padding: 5px; text-align:center" |Patient initially presents with [[upper motor neuron]] deficit ([[spasticity]]) followed by [[lower motor neuron]] deficit ([[flaccidity]]) | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Diffuse gliomatosis]] | ! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Diffuse gliomatosis]]<ref name="pmid23341100">{{cite journal |vauthors=Chen S, Tanaka S, Giannini C, Morris J, Yan ES, Buckner J, Lachance DH, Parney IF |title=Gliomatosis cerebri: clinical characteristics, management, and outcomes |journal=J. Neurooncol. |volume=112 |issue=2 |pages=267–75 |year=2013 |pmid=23341100 |pmc=3907195 |doi=10.1007/s11060-013-1058-x |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 262: | Line 261: | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" |[[Seizure|Seizures]], [[memory loss]], motor weakness, visual symptoms, language deficit, and cognitive and personality changes | | style="background: #F5F5F5; padding: 5px; text-align:center" |[[Seizure|Seizures]], [[memory loss]], motor weakness, visual symptoms, language deficit, and cognitive and personality changes | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Brain tumor|Central nervous system lymphoma]] | ! style="background: #DCDCDC; padding: 5px; text-align:center;" |[[Brain tumor|Central nervous system lymphoma]]<ref name="pmid16547083">{{cite journal |vauthors=Wilne SH, Ferris RC, Nathwani A, Kennedy CR |title=The presenting features of brain tumours: a review of 200 cases |journal=Arch. Dis. Child. |volume=91 |issue=6 |pages=502–6 |year=2006 |pmid=16547083 |pmc=2082784 |doi=10.1136/adc.2005.090266 |url=}}</ref> | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | + | | style="background: #F5F5F5; padding: 5px; text-align:center" | + | ||
| style="background: #F5F5F5; padding: 5px; text-align:center" | - | | style="background: #F5F5F5; padding: 5px; text-align:center" | - | ||
| Line 277: | Line 276: | ||
The most important differential diagnosis when it comes to the rabies presentations include meningitis and encephalitis. It is important to differentiate different rabies from each one of the causes of meningitis/encephalitis, which may differ based on the season of occurrence and the geographical region. | The most important differential diagnosis when it comes to the rabies presentations include meningitis and encephalitis. It is important to differentiate different rabies from each one of the causes of meningitis/encephalitis, which may differ based on the season of occurrence and the geographical region. | ||
The most important viruses to rule out are: | The most important viruses to rule out are:<ref name="pmid12881794">{{cite journal |vauthors=Romero JR, Newland JG |title=Viral meningitis and encephalitis: traditional and emerging viral agents |journal=Semin Pediatr Infect Dis |volume=14 |issue=2 |pages=72–82 |year=2003 |pmid=12881794 |doi=10.1053/spid.2003.127223 |url=}}</ref><ref name="pmid26633824">{{cite journal |vauthors=Xie Y, Tan Y, Chongsuvivatwong V, Wu X, Bi F, Hadler SC, Jiraphongsa C, Sornsrivichai V, Lin M, Quan Y |title=A Population-Based Acute Meningitis and Encephalitis Syndromes Surveillance in Guangxi, China, May 2007-June 2012 |journal=PLoS ONE |volume=10 |issue=12 |pages=e0144366 |year=2015 |pmid=26633824 |pmc=4669244 |doi=10.1371/journal.pone.0144366 |url=}}</ref> | ||
*[[Herpes simplex virus]] type 1 | *[[Herpes simplex virus]] type 1 | ||
*[[Varicella-zoster virus]] | *[[Varicella-zoster virus]] | ||
Revision as of 01:49, 28 September 2017
|
Rabies Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rabies differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Rabies differential diagnosis |
|
Risk calculators and risk factors for Rabies differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The differential diagnosis for rabies deals with eliminating diseases with similar symptoms from the diagnosis. There are many viruses that can appear similar to rabies such as encephalitis and the herpes simplex virus. It is very important to rule out certain diseases such as echovirus and poliovirus. Rabies is a serious disease that needs to be treated quickly if someone is suspected to be infected with the virus.
Differentiating Rabies from other Diseases
Rabies should be differentiated from other causes of headache and decrease consciousness:
| Diseases | History and Physical | Diagnostic tests | Other Findings | |||||
|---|---|---|---|---|---|---|---|---|
| Prodromal symptoms | Fever | Headache | LOC | Neuro Onset | Laboratory Findings | Imaging preferance | ||
| Rabies infection[1] | + | + | + | + | Insidious | Antibody detection in serology
Skin biopsy of injured skin |
MRI | Hydrophobia, aerophobia, dysphagia, and localized pain, weakness or paresthesias |
| Meningitis[2][3] | + | + | + | - | Sudden | CSF analysis:
↑ Protein ↓ Glucose |
CT scan: First choice
MRI: Best choice |
Fever, neck, rigidity |
| Encephalitis[4] | + | + | + | + | Sudden | PCR
CSF analysis and culture reveal the responsible micro-organism |
MRI | Accompany a meningoencephalitis, seizures, hemiparesis, cranial nerve palsies, photophobia, nausea |
| Autoimmune encephalitis[5] | - | +/- | + | +/- | Insidious | Autoantibodies present in both serum and CSF | MRI
EEG |
Memory deficit, dyskinesias, seizures, autonomic instability |
| CNS abscess[6] | + | + | + | + | Insidious | CSF analysis:
↓ Glucose ↑ Protein |
MRI is more sensitive and specific | High grade fever, fatigue,nausea, vomiting |
| Poliomyelitis[7] | + | + | + | + | Sudden | PCR of CSF | MRI | Asymmetric paralysis following a flu-like syndrome |
| Neurosyphilis[8] | - | - | + | + | Insidious | CSF VDRL-specifc | MRI & Lumbar puncture | History of unprotected sex or multiple sexual partners, and genital ulcer (chancre)
Blindness, confusion, depression, abnormal gait |
| Tick paralysis (Dermacentor tick)[9] | - | - | +/- | +/- | Insidious | - | - | History of outdoor activity in Northeastern United States
Tick often still latched to the patient at presentation (often in head and neck area) |
| Botulism[10] | - | - | - | - | Sudden | Toxin test, blood, wound, or stool culture | - | Diplopia, Hyporeflexia, Hypotonia, possible respiratory paralysis, Floppy baby syndrome |
| Tetrodotoxin poisoning[11] | - | - | +/- | +/- | Sudden | - | - | History of consumption of puffer fish species |
| Metabolic disturbances (electrolyte imbalance, hypoglycemia)[12] | - | +/- | - | + | Sudden | Hypoglycemia, hypo and hypernatremia | MRI | Confusion, seizure, palpitations, sweating, dizziness, hypoglycemia |
| Electrolyte disturbance[13] | - | - | - | +/- | Insidious | Hypocalcemia, hypomagnesemia, hypo- or hyperkalemia | Possible arrhythmia | |
| Drug toxicity/Neuroleptic malignant syndrome[14] | - | + | - | + | Sudden | Elevated serum creatine kianse
Hypocalcemia, hypomagnesemia, hypo- and hypernatremia, hyperkalemia, and metabolic acidosis |
Generalized slow wave EEG | Causative medications (eg, neuroleptics, antiemetics, concomitant lithium), dopaminergic withdrawal
Mental status change, rigidity, or dysautonomia |
| Organophosphate toxicity[15] | - | - | - | + | Sudden | Clinical suspicion confirmed with RBC AchE activity | - | History of exposure to insecticide or living in farming environment with : Diarrhea, Miosis, Bradycardia, Lacrimation, Emesis, Salivation, Sweating |
| Ischemic stroke[16]| style="background: #F5F5F5; padding: 5px; text-align:center" | - | - | +/- | + | Sudden | - | MRI for ischemia | Sudden unilateral motor and sensory deficit in a patient with a history of atherosclerotic risk factors (diabetes, hypertension, smoking) or atrial fibrillation | |
| Hemorrhagic stroke[17] | - | - | + | + | Sudden | - | CT scan without contrast | Neck stiffness |
| Subdural hemorrhage[18] | - | - | + | + | Sudden | CSF analysis:
Xanthochromia |
CT scan without contrast | Confusion, dizziness, nausea, vomiting |
| Hypertensive encephalopathy[19] | - | - | + | + | Sudden | - | - | Delirium, cortical blindness, cerebral edema, seizure |
| Wernicke’s encephalopathy[20] | - | - | - | + | Sudden | - | - | Ophthalmoplegia, confusion |
| Amyotrophic lateral sclerosis[21] | - | - | +/- | +/- | Insidious | Normal LP (to rule out DDx) | MRI | Patient initially presents with upper motor neuron deficit (spasticity) followed by lower motor neuron deficit (flaccidity) |
| Diffuse gliomatosis[22] | - | - | + | - | Insidious | Cancer specific molecular characteristics
Normal CSF |
MRI (expansile, T2 hyperintense lesion) | Seizures, memory loss, motor weakness, visual symptoms, language deficit, and cognitive and personality changes |
| Central nervous system lymphoma[23] | + | - | + | +/- | Insidious | CSF cytology, flow cytometry, and stereotactic brain biopsy | MRI (parenchymal or leptomeningeal enhancement) | Associated with immunodeficiency
Focal neurological deficits, neuropsychiatric symptoms, signs of raised intracranial pressure, seizures, and ocular symptoms |
The most important differential diagnosis when it comes to the rabies presentations include meningitis and encephalitis. It is important to differentiate different rabies from each one of the causes of meningitis/encephalitis, which may differ based on the season of occurrence and the geographical region.
The most important viruses to rule out are:[24][25]
- Herpes simplex virus type 1
- Varicella-zoster virus
- (Less commonly) Enteroviruses including:
- Coxsackieviruses
- Echoviruses
- Polioviruses
- Human enteroviruses 68 to 71
In addition, consideration should be given to the local epidemiology of encephalitis caused by arboviruses belonging to several taxonomic groups, including:
- Eastern equine encephalitis viruses
- Western equine encephalitis viruses
- St. Louis encephalitis virus
- Powassan virus
- The California encephalitis virus serogroup
- La Crosse virus
New causes of viral encephalitis are also possible, as was evidenced by the recent outbreak in Malaysia of some 300 cases of encephalitis (mortality rate, 40%) caused by Nipah virus, a newly recognized paramyxovirus. Similarly, well-known viruses may be introduced into new locations, as is illustrated by the recent outbreak of encephalitis due to West Nile virus in the eastern United States. Epidemiological factors (e.g., season, geographic location, and the patient’s age, travel history, and possible exposure to animal bites, rodents, and ticks) may help direct the diagnostic workup.
- ↑ Baevsky RH, Bartfield JM (1993). "Human rabies: a review". Am J Emerg Med. 11 (3): 279–86. PMID 8489675.
- ↑ Tacon CL, Flower O (2012). "Diagnosis and management of bacterial meningitis in the paediatric population: a review". Emerg Med Int. 2012: 320309. doi:10.1155/2012/320309. PMC 3461291. PMID 23050153.
- ↑ Chadwick DR (2005). "Viral meningitis". Br. Med. Bull. 75-76: 1–14. doi:10.1093/bmb/ldh057. PMID 16474042.
- ↑ Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, Kennedy PG (2005). "Viral encephalitis: a review of diagnostic methods and guidelines for management". Eur. J. Neurol. 12 (5): 331–43. doi:10.1111/j.1468-1331.2005.01126.x. PMID 15804262.
- ↑ Lancaster E (2016). "The Diagnosis and Treatment of Autoimmune Encephalitis". J Clin Neurol. 12 (1): 1–13. doi:10.3988/jcn.2016.12.1.1. PMC 4712273. PMID 26754777.
- ↑ Alvis Miranda H, Castellar-Leones SM, Elzain MA, Moscote-Salazar LR (2013). "Brain abscess: Current management". J Neurosci Rural Pract. 4 (Suppl 1): S67–81. doi:10.4103/0976-3147.116472. PMC 3808066. PMID 24174804.
- ↑ Obregón R, Chitnis K, Morry C, Feek W, Bates J, Galway M, Ogden E (2009). "Achieving polio eradication: a review of health communication evidence and lessons learned in India and Pakistan". Bull. World Health Organ. 87 (8): 624–30. PMC 2733260. PMID 19705014.
- ↑ Timmermans M, Carr J (2004). "Neurosyphilis in the modern era". J. Neurol. Neurosurg. Psychiatr. 75 (12): 1727–30. doi:10.1136/jnnp.2004.031922. PMC 1738873. PMID 15548491.
- ↑ Edlow JA, McGillicuddy DC (2008). "Tick paralysis". Infect. Dis. Clin. North Am. 22 (3): 397–413, vii. doi:10.1016/j.idc.2008.03.005. PMID 18755381.
- ↑ Cherington M (2004). "Botulism: update and review". Semin Neurol. 24 (2): 155–63. doi:10.1055/s-2004-830901. PMID 15257512.
- ↑ Hwang DF, Noguchi T (2007). "Tetrodotoxin poisoning". Adv. Food Nutr. Res. 52: 141–236. doi:10.1016/S1043-4526(06)52004-2. PMID 17425946.
- ↑ Josephson MA, Kaul S, Hopkins J, Kvam D, Singh BN (1985). "Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease". Am. Heart J. 109 (1): 41–5. PMID 3966331.
- ↑ Marcelou-Kinti O, Velegraki-Abel A (1988). "[Resistance to amphotericin B and genotypic resistance to 5-fluorocytosine of serotypes A and B of Candida albicans]". Therapie (in French). 43 (2): 121–2. PMID 3043756.
- ↑ Pelonero AL, Levenson JL, Pandurangi AK (1998). "Neuroleptic malignant syndrome: a review". Psychiatr Serv. 49 (9): 1163–72. doi:10.1176/ps.49.9.1163. PMID 9735957.
- ↑ Minton NA, Murray VS (1988). "A review of organophosphate poisoning". Med Toxicol Adverse Drug Exp. 3 (5): 350–75. PMID 3057326.
- ↑ Baldwin K, Orr S, Briand M, Piazza C, Veydt A, McCoy S (2010). "Acute ischemic stroke update". Pharmacotherapy. 30 (5): 493–514. doi:10.1592/phco.30.5.493. PMID 20412000.
- ↑ Bullard CW (1987). "Issues in low-level radioactive waste management". JAPCA. 37 (11): 1337–41. PMID 3443867.
- ↑ Cenic A, Bhandari M, Reddy K (2005). "Management of chronic subdural hematoma: a national survey and literature review". Can J Neurol Sci. 32 (4): 501–6. PMID 16408582.
- ↑ Schwartz RB (2002). "Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions". Neurologist. 8 (1): 22–34. PMID 12803657.
- ↑ Flynn A, Macaluso M, D'Empaire I, Troutman MM (2015). "Wernicke's Encephalopathy: Increasing Clinician Awareness of This Serious, Enigmatic, Yet Treatable Disease". Prim Care Companion CNS Disord. 17 (3). doi:10.4088/PCC.14r01738. PMC 4578911. PMID 26644959.
- ↑ Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A (2015). "A comprehensive review of amyotrophic lateral sclerosis". Surg Neurol Int. 6: 171. doi:10.4103/2152-7806.169561. PMC 4653353. PMID 26629397.
- ↑ Chen S, Tanaka S, Giannini C, Morris J, Yan ES, Buckner J, Lachance DH, Parney IF (2013). "Gliomatosis cerebri: clinical characteristics, management, and outcomes". J. Neurooncol. 112 (2): 267–75. doi:10.1007/s11060-013-1058-x. PMC 3907195. PMID 23341100.
- ↑ Wilne SH, Ferris RC, Nathwani A, Kennedy CR (2006). "The presenting features of brain tumours: a review of 200 cases". Arch. Dis. Child. 91 (6): 502–6. doi:10.1136/adc.2005.090266. PMC 2082784. PMID 16547083.
- ↑ Romero JR, Newland JG (2003). "Viral meningitis and encephalitis: traditional and emerging viral agents". Semin Pediatr Infect Dis. 14 (2): 72–82. doi:10.1053/spid.2003.127223. PMID 12881794.
- ↑ Xie Y, Tan Y, Chongsuvivatwong V, Wu X, Bi F, Hadler SC, Jiraphongsa C, Sornsrivichai V, Lin M, Quan Y (2015). "A Population-Based Acute Meningitis and Encephalitis Syndromes Surveillance in Guangxi, China, May 2007-June 2012". PLoS ONE. 10 (12): e0144366. doi:10.1371/journal.pone.0144366. PMC 4669244. PMID 26633824.